SOP Guide for Pharma

SOP for Labeling and Segregation of Raw Materials in Quarantine Area – V 2.0

SOP for Labeling and Segregation of Raw Materials in Quarantine Area – V 2.0

Standard Operating Procedure for Labeling and Segregation of Raw Materials in Quarantine Area

Department Warehouse / Quality Assurance / Quality Control
SOP No. SOP/RM/061/2025
Supersedes SOP/RM/061/2022
Page No. Page 1 of 15
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for labeling and segregating raw materials in the quarantine area to prevent cross-contamination, ensure traceability, and maintain compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all raw materials received at the facility that require quarantine prior to approval, including Active Pharmaceutical Ingredients (APIs), excipients, and packaging materials. It covers procedures for labeling, segregation, and documentation in the quarantine area.

3. Responsibilities

  • Warehouse Personnel: Ensure proper labeling and segregation of raw materials in the quarantine area and maintain accurate records.
  • Quality Assurance (QA): Review labeling and segregation practices for compliance with GMP and approve or reject materials.
  • Quality Control (QC): Conduct sampling and testing of quarantined materials to determine their status.

4. Accountability

The Warehouse Manager is responsible for ensuring raw materials are correctly labeled and segregated in the quarantine area. The QA Manager

ensures compliance with labeling standards, while the QC Manager oversees sampling and testing of quarantined materials.

5. Procedure

5.1 Quarantine Area Setup

  1. Designation of Quarantine Area:
    • Assign a dedicated, clearly marked area for quarantined materials, separate from approved and rejected materials.
    • Ensure proper environmental controls (temperature, humidity) to protect material integrity.
  2. Access Control:
    • Restrict access to authorized personnel only and maintain an entry log for the quarantine area.
    • Post clear signage indicating “QUARANTINE AREA – AUTHORIZED PERSONNEL ONLY.”

5.2 Labeling of Raw Materials in Quarantine

  1. Labeling Requirements:
    • Each quarantined material must be labeled with:
      • “UNDER TEST” or “QUARANTINE” status.
      • Material name and code.
      • Batch/Lot number.
      • Supplier name.
      • Date of receipt.
      • Assigned Goods Receipt Note (GRN) number.
    • Use color-coded labels for easy identification:
      • Yellow: Under Test.
      • Red: Rejected.
      • Green: Approved (post-testing).
    • Document all labeling details in the Quarantine Labeling Log (Annexure-1).

5.3 Segregation of Raw Materials in Quarantine

  1. Segregation by Material Type:
    • Segregate materials based on type (e.g., APIs, excipients, solvents) to prevent cross-contamination.
    • Store hazardous or temperature-sensitive materials in designated areas with appropriate controls.
  2. Segregation by Testing Status:
    • Separate materials awaiting testing from those with completed testing but pending QA approval.
    • Clearly mark areas for materials under test and materials pending disposition.
    • Document segregation details in the Quarantine Segregation Log (Annexure-2).

5.4 Handling of Quarantined Materials

  1. Material Movement:
    • Do not move quarantined materials out of the quarantine area without QA authorization.
    • Record all material movements in the Quarantine Movement Log (Annexure-3).
  2. Sampling Procedures:
    • QC personnel must follow standard sampling procedures in designated sampling zones within the quarantine area.
    • Record sampling activities in the Quarantine Sampling Log (Annexure-4).

5.5 Final Disposition of Quarantined Materials

  1. Approval or Rejection:
    • QA reviews test results and inspection reports to approve or reject materials.
    • Update labels to reflect final status and move materials to approved or rejected storage areas accordingly.
    • Document final disposition in the Quarantine Disposition Log (Annexure-5).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • QC: Quality Control
  • GRN: Goods Receipt Note

7. Documents

  1. Quarantine Labeling Log (Annexure-1)
  2. Quarantine Segregation Log (Annexure-2)
  3. Quarantine Movement Log (Annexure-3)
  4. Quarantine Sampling Log (Annexure-4)
  5. Quarantine Disposition Log (Annexure-5)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • EU Guidelines on Good Distribution Practices (GDP)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Quarantine Labeling Log

Date Material Name Batch Number Label Status GRN Number Labeled By Remarks
01/02/2025 API-X X-2025-001 Under Test GRN-1001 Ravi Kumar Awaiting QC Sampling
01/02/2025 Excipient-Y Y-2025-002 Under Test GRN-1002 Sunita Sharma Pending Documentation Verification

Annexure-2: Quarantine Segregation Log

Date Material Name Batch Number Segregation Type Location Segregated By Remarks
01/02/2025 API-X X-2025-001 APIs Quarantine Zone A Anil Mehta Properly Separated from Excipients

Annexure-3: Quarantine Movement Log

Date Material Name Batch Number From To Moved By Authorized By
02/02/2025 API-X X-2025-001 Quarantine Zone A QC Sampling Area Ajay Singh Anjali Mehta (QA)

Annexure-4: Quarantine Sampling Log

Date Material Name Batch Number Sampled By Test Type Remarks
02/02/2025 API-X X-2025-001 Priya Desai Identity and Purity Results Pending

Annexure-5: Quarantine Disposition Log

Date Material Name Batch Number Disposition Approved By Remarks
03/02/2025 API-X X-2025-001 Approved Anjali Mehta Ready for Use
03/02/2025 Excipient-Y Y-2025-002 Rejected Anjali Mehta Failed Identity Test

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Enhanced Segregation and Labeling Procedures Compliance Improvement QA Head
Exit mobile version